CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 21 enrolled
Drug / intervention
First Treatment Period +2 moredrug
Likely dose
First Treatment Period 70 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02322879
NCT02322879Phase 4Completed

Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing

Beth Israel Deaconess Medical Center·interventional·Posted Dec 23, 2014·Updated Sep 1, 2017

In Brief

A Phase 4 clinical trial evaluating First Treatment Period, Washout, and 1 other intervention for Acetaminophen Toxicity. Completed, enrolled 21 participants across 1 site.

Detailed Summary

A purpose of this protocol is to is to compare the metabolites of the toxic bioactivating pathway after acetaminophen alone or acetaminophen followed by Propylene Glycol (PG) and to determine if it prevents the formation of the toxic metabolites of acetaminophen.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsHarvard University

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 23, 2014
Enrollment StartMay 1, 2013
Primary CompletionAug 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 11.5 years ago

Interventions

First Treatment Perioddrug

(duration: 14 days) Subjects will be randomized to receive either of the 2 interventions (4 grams of solid acetaminophen formulation for two weeks vs. 4 grams of solid acetaminophen formulation + 70 mg/kg/day of liquid propylene glycol)

Washoutother

(duration: 14 days) At the end of the First intervention period all participants will enter a washout period.

Second Treatment Perioddrug

(duration: 14 days) At the end of the washout period, participants will receive the alternative intervention.